Results 101 to 110 of about 44,445 (364)

Ectopic pleural thymoma with T-cell lymphocytosis and bone metastasis: a case report

open access: yesBMC Pulmonary Medicine
Background The diagnostic complexities that arise in radiographic distinction between ectopic pleural thymoma and other thoracic neoplasms are substantial, with instances of co-occurring T-cell lymphocytosis and osseous metastasis being exceedingly rare.
Jun Li   +4 more
doaj   +1 more source

Integrated therapeutic approach to giant solitary fibrous tumor of the pleura: report of a case and review of the literature

open access: yesOpen Medicine, 2016
The fibrous tumors of the pleura are rare primary tumors, accounting for 5% of malignant pleural neoplasms, which generally originate from sub-mesothelial mesenchymal tissue of the visceral pleura. These tumours generally exhibit clinical benign behavior
Perrotta Fabio   +13 more
doaj   +1 more source

Eosinophilic fasciitis (Shulman's disease): review and comparative evaluation of seven patients. [PDF]

open access: yes, 2019
OBJECTIVES: Eosinophilic fasciitis (EF) was described in 1974 by Shulman as a rare fibrosing connective tissue disease of unknown etiology. An undetermined trigger is thought to lead to the degranulation of eosinophils that interact with fibroblasts and
Cimbron, M   +3 more
core   +1 more source

Network-based community detection of comorbidities and their association with SARS-CoV-2 virus during COVID-19 pathogenesis [PDF]

open access: yesarXiv, 2022
Recent studies emphasized the necessity to identify key (human) biological processes and pathways targeted by the Coronaviridae family of viruses, especially SARS-CoV-2. COVID-19 caused up to 33-55\% death rates in COVID-19 patients with malignant neoplasms and Alzheimer's disease.
arxiv  

Pan‐cancer analysis shapes the understanding of cancer biology and medicine

open access: yesCancer Communications, EarlyView.
Abstract Advances in multi‐omics datasets and analytical methods have revolutionized cancer research, offering a comprehensive, pan‐cancer perspective. Pan‐cancer studies identify shared mechanisms and unique traits across different cancer types, which are reshaping diagnostic and treatment strategies.
Xiaoping Cen   +21 more
wiley   +1 more source

The Potential Malignancy of a Solitary Fibrous Tumour of the Lung

open access: yesCase Reports in Pathology, 2015
Solitary fibrous tumours (SFTs) are rare neoplasms that in the majority of cases are benign. We present the case of a 52-year-old male, with a 23-year history of a slow growing pleural mass, presenting to our department with worsening dyspnoea and ...
Rajeev Shukla   +5 more
doaj   +1 more source

Imatinib-induced interstitial pneumonitis – a literature review and case report [PDF]

open access: yes, 2020
Imatinib is generally well tolerated, with mild common side effects such as nausea and vomiting, diarrhea, muscle cramps, fatigue, skin rash and edema; however, pulmonary complications are uncommon. A 73-year-old woman undergoing one month treatment with
Ciulei, George   +12 more
core   +1 more source

Right Cardiac Intracavitary Metastases from a Primary Intracranial Myxofibrosarcoma [PDF]

open access: yes, 2016
Primary intracranial myxofibrosarcoma is exceedingly rare, with less than 10 cases published. We present a case of a 23-year-old man with previous history of a primary low grade myxofibrosarcoma of the left parietal-occipital convexity resected in March ...
Alpuim Costa, D   +3 more
core   +1 more source

DeScarGAN: Disease-Specific Anomaly Detection with Weak Supervision [PDF]

open access: yesarXiv, 2020
Anomaly detection and localization in medical images is a challenging task, especially when the anomaly exhibits a change of existing structures, e.g., brain atrophy or changes in the pleural space due to pleural effusions. In this work, we present a weakly supervised and detail-preserving method that is able to detect structural changes of existing ...
arxiv  

An open‐label, single‐arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR‐positive, HER2‐negative advanced breast cancer patients: BRIGHT‐1 trial

open access: yesCancer Communications, EarlyView.
Abstract Background Bireociclib (XZP‐3287) is a novel selective cyclin‐dependent kinase 4 and 6 (CDK4/6) inhibitor, with a favorable safety profile demonstrated in preclinical and phase I studies. BRIGHT‐1 aimed to further explore the efficacy and safety of bireociclib monotherapy in patients with locally advanced, recurrent or metastatic, hormone ...
Jiayu Wang   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy